SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-105892
Filing Date
2024-04-23
Accepted
2024-04-23 07:05:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d641601ddefa14a.htm DEFA14A 13508
2 GRAPHIC g641601dsp001.jpg GRAPHIC 194720
3 GRAPHIC g641601dsp002.jpg GRAPHIC 198501
  Complete submission text file 0001193125-24-105892.txt   556416
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37813 | Film No.: 24862674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)